A detailed history of Bessemer Group Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Bessemer Group Inc holds 790 shares of WVE stock, worth $5,561. This represents 0.0% of its overall portfolio holdings.

Number of Shares
790
Holding current value
$5,561
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 01, 2025

BUY
$5.48 - $8.1 $4,329 - $6,399
790 New
790 $5,000
Q3 2020

Nov 12, 2020

SELL
$8.49 - $19.54 $665,616 - $1.53 Million
-78,400 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$7.44 - $11.29 $583,296 - $885,135
78,400 New
78,400 $816,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $611M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.